Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hořejší V[au]:

Search results

Items: 1 to 50 of 216

1.

The mannose 6-phosphate/insulin-like growth factor 2 receptor mediates plasminogen-induced efferocytosis.

Ohradanova-Repic A, Machacek C, Donner C, Mühlgrabner V, Petrovčíková E, Zahradníková A Jr, Vičíková K, Hořejší V, Stockinger H, Leksa V.

J Leukoc Biol. 2019 Mar;105(3):519-530. doi: 10.1002/JLB.1AB0417-160RR. Epub 2019 Jan 18.

2.

Tumour devascularisation as a potential immunotherapeutic strategy.

Buchler T, Vasek P, Spisek R, Skrobanek P, Horejsi V.

Oncoimmunology. 2018 Oct 11;8(1):e1526614. doi: 10.1080/2162402X.2018.1526614. eCollection 2019.

3.

The use of styrene-maleic acid copolymer (SMA) for studies on T cell membrane rafts.

Angelisová P, Ballek O, Sýkora J, Benada O, Čajka T, Pokorná J, Pinkas D, Hořejší V.

Biochim Biophys Acta Biomembr. 2019 Jan;1861(1):130-141. doi: 10.1016/j.bbamem.2018.08.006. Epub 2018 Aug 14.

PMID:
30463696
4.

Correction to: EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.

Zjablovskaja P, Kardosova M, Danek P, Angelisova P, Benoukraf T, Wurm AA, Kalina T, Sian S, Balastik M, Delwel R, Brdicka T, Tenen DG, Behre G, Fiore F, Malissen B, Horejsi V, Alberich-Jorda M.

Cell Death Differ. 2019 Jan;26(1):198. doi: 10.1038/s41418-018-0146-z.

5.

Fab antibody fragment-functionalized liposomes for specific targeting of antigen-positive cells.

Ohradanova-Repic A, Nogueira E, Hartl I, Gomes AC, Preto A, Steinhuber E, Mühlgrabner V, Repic M, Kuttke M, Zwirzitz A, Prouza M, Suchanek M, Wozniak-Knopp G, Horejsi V, Schabbauer G, Cavaco-Paulo A, Stockinger H.

Nanomedicine. 2018 Jan;14(1):123-130. doi: 10.1016/j.nano.2017.09.003. Epub 2017 Sep 19.

PMID:
28939491
6.

EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.

Zjablovskaja P, Kardosova M, Danek P, Angelisova P, Benoukraf T, Wurm AA, Kalina T, Sian S, Balastik M, Delwel R, Brdicka T, Tenen DG, Behre G, Fiore F, Malissen B, Horejsi V, Alberich-Jorda M.

Cell Death Differ. 2017 Apr;24(4):705-716. doi: 10.1038/cdd.2017.6. Epub 2017 Feb 10. Erratum in: Cell Death Differ. 2019 Jan;26(1):198.

7.

[Antitumour Weapons of the Immune System].

Hořejší V.

Klin Onkol. 2015;28 Suppl 4:4S15-22. Review. Czech.

PMID:
26647884
8.

CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.

Engel P, Boumsell L, Balderas R, Bensussan A, Gattei V, Horejsi V, Jin BQ, Malavasi F, Mortari F, Schwartz-Albiez R, Stockinger H, van Zelm MC, Zola H, Clark G.

J Immunol. 2015 Nov 15;195(10):4555-63. doi: 10.4049/jimmunol.1502033.

9.

Membrane microdomains in immunoreceptor signaling.

Horejsi V, Hrdinka M.

FEBS Lett. 2014 Aug 1;588(15):2392-7. doi: 10.1016/j.febslet.2014.05.047. Epub 2014 Jun 6. Review.

10.

MicroRNA editing facilitates immune elimination of HCMV infected cells.

Nachmani D, Zimmermann A, Oiknine Djian E, Weisblum Y, Livneh Y, Khanh Le VT, Galun E, Horejsi V, Isakov O, Shomron N, Wolf DG, Hengel H, Mandelboim O.

PLoS Pathog. 2014 Feb 27;10(2):e1003963. doi: 10.1371/journal.ppat.1003963. eCollection 2014 Feb.

11.

Palmitoylated transmembrane adaptor proteins in leukocyte signaling.

Stepanek O, Draber P, Horejsi V.

Cell Signal. 2014 May;26(5):895-902. doi: 10.1016/j.cellsig.2014.01.007. Epub 2014 Jan 15. Review.

PMID:
24440308
12.

PAG--a multipurpose transmembrane adaptor protein.

Hrdinka M, Horejsi V.

Oncogene. 2014 Oct 9;33(41):4881-92. doi: 10.1038/onc.2013.485. Epub 2013 Nov 11. Review.

PMID:
24213579
13.

Nonredundant roles of Src-family kinases and Syk in the initiation of B-cell antigen receptor signaling.

Stepanek O, Draber P, Drobek A, Horejsi V, Brdicka T.

J Immunol. 2013 Feb 15;190(4):1807-18. doi: 10.4049/jimmunol.1202401. Epub 2013 Jan 18.

14.

The transmembrane region is responsible for targeting of adaptor protein LAX into "heavy rafts".

Hrdinka M, Otahal P, Horejsi V.

PLoS One. 2012;7(5):e36330. doi: 10.1371/journal.pone.0036330. Epub 2012 May 25.

15.

LST1/A is a myeloid leukocyte-specific transmembrane adaptor protein recruiting protein tyrosine phosphatases SHP-1 and SHP-2 to the plasma membrane.

Draber P, Stepanek O, Hrdinka M, Drobek A, Chmatal L, Mala L, Ormsby T, Angelisova P, Horejsi V, Brdicka T.

J Biol Chem. 2012 Jun 29;287(27):22812-21. doi: 10.1074/jbc.M112.339143. Epub 2012 May 15. Erratum in: J Biol Chem. 2013 Sep 27;288(39):28309.

16.

SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling.

Draber P, Vonkova I, Stepanek O, Hrdinka M, Kucova M, Skopcova T, Otahal P, Angelisova P, Horejsi V, Yeung M, Weiss A, Brdicka T.

Mol Cell Biol. 2011 Nov;31(22):4550-62. doi: 10.1128/MCB.05817-11. Epub 2011 Sep 19.

17.

Btk is a positive regulator in the TREM-1/DAP12 signaling pathway.

Ormsby T, Schlecker E, Ferdin J, Tessarz AS, Angelisová P, Köprülü AD, Borte M, Warnatz K, Schulze I, Ellmeier W, Horejsí V, Cerwenka A.

Blood. 2011 Jul 28;118(4):936-45. doi: 10.1182/blood-2010-11-317016. Epub 2011 Jun 9.

18.

Interaction of late apoptotic and necrotic cells with vitronectin.

Stepanek O, Brdicka T, Angelisova P, Horvath O, Spicka J, Stockbauer P, Man P, Horejsi V.

PLoS One. 2011 May 4;6(5):e19243. doi: 10.1371/journal.pone.0019243.

19.

Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148.

Stepanek O, Kalina T, Draber P, Skopcova T, Svojgr K, Angelisova P, Horejsi V, Weiss A, Brdicka T.

J Biol Chem. 2011 Jun 24;286(25):22101-12. doi: 10.1074/jbc.M110.196733. Epub 2011 May 4.

20.

PRR7 is a transmembrane adaptor protein expressed in activated T cells involved in regulation of T cell receptor signaling and apoptosis.

Hrdinka M, Dráber P, Stepánek O, Ormsby T, Otáhal P, Angelisová P, Brdicka T, Paces J, Horejsí V, Drbal K.

J Biol Chem. 2011 Jun 3;286(22):19617-29. doi: 10.1074/jbc.M110.175117. Epub 2011 Apr 1.

21.

The effects of membrane compartmentalization of csk on TCR signaling.

Otáhal P, Pata S, Angelisová P, Hořejší V, Brdička T.

Biochim Biophys Acta. 2011 Feb;1813(2):367-76. doi: 10.1016/j.bbamcr.2010.12.003. Epub 2010 Dec 15.

22.

Pre-sorting endosomal transport of the GPI-anchored protein, CD59, is regulated by EHD1.

Cai B, Katafiasz D, Horejsi V, Naslavsky N.

Traffic. 2011 Jan;12(1):102-20. doi: 10.1111/j.1600-0854.2010.01135.x. Epub 2010 Nov 12.

23.

LAT--an important raft-associated transmembrane adaptor protein. Delivered on 6 July 2009 at the 34th FEBS Congress in Prague, Czech Republic.

Horejsí V, Otáhal P, Brdicka T.

FEBS J. 2010 Nov;277(21):4383-97. doi: 10.1111/j.1742-4658.2010.07831.x. Epub 2010 Sep 28.

24.

A new type of membrane raft-like microdomains and their possible involvement in TCR signaling.

Otáhal P, Angelisová P, Hrdinka M, Brdicka T, Novák P, Drbal K, Horejsí V.

J Immunol. 2010 Apr 1;184(7):3689-96. doi: 10.4049/jimmunol.0902075. Epub 2010 Mar 5.

25.

Czech bibliometric system fosters mediocre research.

Konvalinka J, Illnerová H, Hobza P, Horejsí V, Holý A, Jungwirth P, Paces V, Martásek P, Zlatuska J.

Nature. 2009 Aug 27;460(7259):1079. doi: 10.1038/4601079c. No abstract available.

PMID:
19713911
26.

HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides.

Lo Monaco E, Sibilio L, Melucci E, Tremante E, Suchànek M, Horejsi V, Martayan A, Giacomini P.

J Immunol. 2008 Oct 15;181(8):5442-50.

27.

Antibody array analysis with label-based detection and resolution of protein size.

Wu W, Slåstad H, de la Rosa Carrillo D, Frey T, Tjønnfjord G, Boretti E, Aasheim HC, Horejsi V, Lund-Johansen F.

Mol Cell Proteomics. 2009 Feb;8(2):245-57. doi: 10.1074/mcp.M800171-MCP200. Epub 2008 Sep 16.

28.

The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1.

Veracini L, Simon V, Richard V, Schraven B, Horejsi V, Roche S, Benistant C.

J Cell Biol. 2008 Aug 11;182(3):603-14. doi: 10.1083/jcb.200705102.

29.

LFA-1-mediated leukocyte adhesion regulated by interaction of CD43 with LFA-1 and CD147.

Khunkaewla P, Schiller HB, Paster W, Leksa V, Cermák L, Andera L, Horejsí V, Stockinger H.

Mol Immunol. 2008 Mar;45(6):1703-11. Epub 2007 Nov 9.

PMID:
17996943
30.

Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells.

Iwaki S, Spicka J, Tkaczyk C, Jensen BM, Furumoto Y, Charles N, Kovarova M, Rivera J, Horejsi V, Metcalfe DD, Gilfillan AM.

Cell Signal. 2008 Jan;20(1):195-205. Epub 2007 Oct 16.

31.

Deletion of the LIME adaptor protein minimally affects T and B cell development and function.

Grégoire C, Simova S, Wang Y, Sansoni A, Richelme S, Schmidt-Giese A, Simeoni L, Angelisova P, Reinhold D, Schraven B, Horejsi V, Malissen B, Malissen M.

Eur J Immunol. 2007 Nov;37(11):3259-69.

32.

The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn.

Hong H, Kitaura J, Xiao W, Horejsi V, Ra C, Lowell CA, Kawakami Y, Kawakami T.

Blood. 2007 Oct 1;110(7):2511-9. Epub 2007 May 18. Erratum in: Blood. 2008 Mar 15;111(6):3299.

33.

HLA-G levels in serum and plasma.

Rudstein-Svetlicky N, Loewenthal R, Horejsi V, Gazit E.

Tissue Antigens. 2007 Apr;69 Suppl 1:140-2.

PMID:
17445189
34.

A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation.

Smida M, Posevitz-Fejfar A, Horejsi V, Schraven B, Lindquist JA.

Blood. 2007 Jul 15;110(2):596-615. Epub 2007 Mar 27.

35.

Dendritic cells sensitize TCRs through self-MHC-mediated Src family kinase activation.

Meraner P, Horejsí V, Wolpl A, Fischer GF, Stingl G, Maurer D.

J Immunol. 2007 Feb 15;178(4):2262-71.

36.

Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells.

Tessarz AS, Weiler S, Zanzinger K, Angelisová P, Horejsí V, Cerwenka A.

J Immunol. 2007 Feb 15;178(4):1991-9.

37.

Dysregulation of Src family kinases in mast cells from epilepsy-resistant ASK versus epilepsy-prone EL mice.

Kitaura J, Kawakami Y, Maeda-Yamamoto M, Horejsi V, Kawakami T.

J Immunol. 2007 Jan 1;178(1):455-62.

38.

Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.

Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B.

Blood. 2007 Apr 1;109(7):2806-14.

39.

HLA-G levels in serum and plasma.

Rudstein-Svetlicky N, Loewenthal R, Horejsi V, Gazit E.

Tissue Antigens. 2006 Feb;67(2):111-6.

PMID:
16441481
40.

Conformational variation of surface class II MHC proteins during myeloid dendritic cell differentiation accompanies structural changes in lysosomal MIIC.

Potolicchio I, Chitta S, Xu X, Fonseca D, Crisi G, Horejsi V, Strominger JL, Stern LJ, Raposo G, Santambrogio L.

J Immunol. 2005 Oct 15;175(8):4935-47.

41.

The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules.

Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsí V, Goldman-Wohl D, Yagel S, Mandelboim O.

J Immunol. 2005 Oct 15;175(8):4866-74.

42.

TGF-beta-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen.

Leksa V, Godar S, Schiller HB, Fuertbauer E, Muhammad A, Slezakova K, Horejsi V, Steinlein P, Weidle UH, Binder BR, Stockinger H.

J Cell Sci. 2005 Oct 1;118(Pt 19):4577-86.

43.

Non-lineage antigens: section report.

Horváth O, Drbel K, Angelisová P, Hilgert I, Horejsí V.

Cell Immunol. 2005 Jul-Aug;236(1-2):42-7. Epub 2005 Sep 12.

PMID:
16165117
44.

Transmembrane adaptor molecules: a new category of lymphoid-cell markers.

Tedoldi S, Paterson JC, Hansmann ML, Natkunam Y, Rüdiger T, Angelisova P, Du MQ, Roberton H, Roncador G, Sanchez L, Pozzobon M, Masir N, Barry R, Pileri S, Mason DY, Marafioti T, Horejsí V.

Blood. 2006 Jan 1;107(1):213-21. Epub 2005 Sep 13.

45.

The HLDA8 blind panel: findings and conclusions.

Swart B, Salganik MP, Wand MP, Tinckam K, Milford EL, Drbal K, Angelisova P, Horejsi V, Macardle P, Bailey S, Hollemweguer E, Hodge G, Nairn J, Millard D, Dagdeviren A, Dandie GW, Zola H; HLDA8 blind panel.

J Immunol Methods. 2005 Oct 20;305(1):75-83. Epub 2005 Aug 15.

PMID:
16126219
46.

CD molecules 2005: human cell differentiation molecules.

Zola H, Swart B, Nicholson I, Aasted B, Bensussan A, Boumsell L, Buckley C, Clark G, Drbal K, Engel P, Hart D, Horejsí V, Isacke C, Macardle P, Malavasi F, Mason D, Olive D, Saalmueller A, Schlossman SF, Schwartz-Albiez R, Simmons P, Tedder TF, Uguccioni M, Warren H.

Blood. 2005 Nov 1;106(9):3123-6. Epub 2005 Jul 14.

47.
48.

Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B-cell development and function.

Wang Y, Horvath O, Hamm-Baarke A, Richelme M, Grégoire C, Guinamard R, Horejsi V, Angelisova P, Spicka J, Schraven B, Malissen B, Malissen M.

Mol Cell Biol. 2005 Jun;25(11):4455-65.

49.

Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.

Gesierich S, Paret C, Hildebrand D, Weitz J, Zgraggen K, Schmitz-Winnenthal FH, Horejsi V, Yoshie O, Herlyn D, Ashman LK, Zöller M.

Clin Cancer Res. 2005 Apr 15;11(8):2840-52.

50.

Lipid rafts and their roles in T-cell activation.

Horejsí V.

Microbes Infect. 2005 Feb;7(2):310-6. Epub 2005 Jan 8. Review.

PMID:
15715974

Supplemental Content

Loading ...
Support Center